United States · FDA National Drug Code directory
MIDODRINE HYDROCHLORIDE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 46708-339_38173ca4-7b7e-4c91-b12c-7cce5bfaba84
- Product NDC
- 46708-339
- Form
- TABLET
- Composition / generic term
- MIDODRINE HYDROCHLORIDE
- Labeler
- Alembic Pharmaceuticals Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210122
- Source listing expiry
- 20261231
Source-listed ingredients
- MIDODRINE HYDROCHLORIDE — 5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (46708-339-31) · 46708-339-31
- 500 TABLET in 1 BOTTLE (46708-339-71) · 46708-339-71
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →